| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879803 Methods of treatment involving the protease for activating clotting factor VII |
| 02/01/2011 | US7879800 Purification of API from blood plasma or from plasma fractions to obtain pharmaceutical grade API on a commercial scale and is highly stable |
| 02/01/2011 | US7879799 Preparing immunoglobulin specific for deglycosylated membrane proteins; for use in monitoring dynamic organization of the plasma membranes |
| 02/01/2011 | US7879791 Regulation of T cell-mediated immunity by tryptophan |
| 02/01/2011 | US7879611 Using insertional mutagenesis to identify gain and loss of function mutations; directed evolution |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879586 Gene encoding methylated catechin synthase |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879566 Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease |
| 02/01/2011 | US7879565 Modulators that promote cell surface expression of odorant receptors |
| 02/01/2011 | US7879564 Use of the receptor GPR86 |
| 02/01/2011 | US7879561 Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4 |
| 02/01/2011 | US7879557 Isolated fluorescent protein from Clytia gregaria CGFP and use thereof |
| 02/01/2011 | US7879546 Using human papilloma virus expression profiles as diagnostic/evaluative tool in detection viral induced neoplasia |
| 02/01/2011 | US7879544 Using white adipose (WAT) or stromal vascular tissue (SVT) specific gene expression profile as evaluative tools in prevention and detection of adipogenesis and diabetes |
| 02/01/2011 | US7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879320 Sustained release interferon dosage form for use in treatment of multiple sclerosis |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 02/01/2011 | US7879318 Using thrombopoietin to reduce deleterious effects of ischemia-reperfusion in tissue or organs in mammals |
| 02/01/2011 | US7879115 Method for using a static electric field to induce crystallization and to control crystal form |
| 02/01/2011 | US7879111 System and method for RFID transfer of MAC, keys |
| 02/01/2011 | CA2551193C Live genetically attenuated malaria vaccine |
| 02/01/2011 | CA2547256C Adenovirus-transfected primary cells and methods of pathway mapping |
| 02/01/2011 | CA2470971C Use of pharmaceutical composition containing epidermal growth factor (egf) for preventing diabetic limb amputation |
| 02/01/2011 | CA2408685C Liquid pharmaceutical composition containing an erythropoietin derivate |
| 02/01/2011 | CA2394740C Method for obtaining proteins having improved functional characteristics |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2359013C Compositions and methods for packaging of alphavirus vectors |
| 02/01/2011 | CA2345882C Methods and compositions for the prevention and treatment of anemia |
| 02/01/2011 | CA2319084C Novel collectin |
| 02/01/2011 | CA2288943C Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/01/2011 | CA2274902C Submucosa extracts |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 01/27/2011 | WO2011011789A1 Methods and compositions for treating neuronal damage or degeneration |
| 01/27/2011 | WO2011011713A1 Compositions and methods of use for post-radiation protection |
| 01/27/2011 | WO2011011674A2 Production of erythropoiesis stimulating protein using metal ions |
| 01/27/2011 | WO2011011584A1 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein |
| 01/27/2011 | WO2011011412A2 Transgenic plants having increased biomass |
| 01/27/2011 | WO2011011388A2 Neuregulin induced regeneraton of heart muscle muscle |
| 01/27/2011 | WO2011011347A2 Functionalization of silk material by avidin-biotin interaction |
| 01/27/2011 | WO2011011273A1 The use of dimerization domain component stacks to modulate plant architecture |
| 01/27/2011 | WO2011011073A1 Site-specific pegylated or site-specific lipidated igf-1 and analogues of igf-1 |
| 01/27/2011 | WO2011011072A2 Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59 |
| 01/27/2011 | WO2011011071A2 Analogues of insulin-like growth factor-1 (igf-1) |
| 01/27/2011 | WO2011010372A1 Method and kit for evaluation of substance, method for screening of substance, and method and kit for determination of presence of occurrence of diabetic nephropathy or potential risk of diabetic nephropathy |
| 01/27/2011 | WO2011010337A1 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins |
| 01/27/2011 | WO2011009944A1 Compounds modulators of vegf activity and uses thereof |
| 01/27/2011 | WO2011009626A1 Compounds which inhibit muscle contraction |
| 01/27/2011 | WO2011009218A1 Raf dimers and uses thereof |
| 01/27/2011 | WO2010122506A3 Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof |
| 01/27/2011 | WO2010115033A3 Nucleotide repeat expansion-associated polypeptides and uses thereof |
| 01/27/2011 | WO2010112848A3 Inhibition of biofilm organisms |
| 01/27/2011 | WO2010100569A3 Natural biodegradable adhesive from the silk |
| 01/27/2011 | WO2010008823A8 Purification of modified cytokines |
| 01/27/2011 | WO2009130031A9 Artificial protein scaffolds |
| 01/27/2011 | US20110023184 Axmi-205 pesticidal gene and methods for its use |
| 01/27/2011 | US20110023179 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods |
| 01/27/2011 | US20110023168 Soybean variety a1016515 |
| 01/27/2011 | US20110023167 Soybean variety a1016334 |
| 01/27/2011 | US20110023166 Soybean variety a1016332 |
| 01/27/2011 | US20110023165 Soybean variety a1016317 |
| 01/27/2011 | US20110023164 Soybean variety a1015484 |
| 01/27/2011 | US20110021761 Segmented Polymers and Their Conjugates |
| 01/27/2011 | US20110021760 Crystalline vap-1 and uses thereof |
| 01/27/2011 | US20110021759 Diagnosis and Treatment of Blood Disorders |
| 01/27/2011 | US20110021754 Biopolymeric membranes |
| 01/27/2011 | US20110021753 Method for Preparing Porous Collagen Matrices |
| 01/27/2011 | US20110021752 Tropoelastin Derivatives |
| 01/27/2011 | US20110021751 Plasmid Vector |
| 01/27/2011 | US20110021750 Oral cancer biomarker and inspection method using the same |
| 01/27/2011 | US20110021746 Universal fibronectin type iii binding-domain libraries |
| 01/27/2011 | US20110021744 Process for preparing purified drug conjugates |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021610 Aromatic prenyltransferase from hop |
| 01/27/2011 | US20110021603 TRPM-2 Antisense Therapy |
| 01/27/2011 | US20110021445 Compositions and methods for treating erectile dysfunction |
| 01/27/2011 | US20110021444 Compositions for controlling hair growth |
| 01/27/2011 | US20110021442 Cell preamble runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 01/27/2011 | US20110021441 Conjugate comprising p21 protein for the treatment of cancer |
| 01/27/2011 | US20110021431 Methods And Compositions For Medical Articles Produced From Proteinaceous Compounds |
| 01/27/2011 | US20110021429 Renoprotection by growth hormone-releasing hormone and agonists |
| 01/27/2011 | US20110021424 Polypeptide derived from protein a and able to bind pdgf |
| 01/27/2011 | US20110021423 Rapid Acting Insulin Analogues |
| 01/27/2011 | US20110021414 Chimeric Phage Tail Proteins and Uses Thereof |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110021412 Human Receptor Proteins; Related Reagents and Methods |
| 01/27/2011 | US20110021411 Reverse protein |
| 01/27/2011 | US20110021375 Sphingosine 1-Phosphate Receptor Gene, SPPR |
| 01/27/2011 | US20110020951 Purified sr-p70 protein |
| 01/27/2011 | US20110020926 Novel taste-modifying polypeptide nas, dna thereof and use thereof |
| 01/27/2011 | US20110020912 Method for the construction of randomized gene sequence libraries in cells |
| 01/27/2011 | US20110020907 Viruses lacking epithelial cell receptor entry |
| 01/27/2011 | US20110020868 Bacterial leader sequences for increased expression |